logo
episode-header-image
Jan 2022
41m 13s

20VC: 23andMe's Anne Wojcicki on How To ...

Harry Stebbings
About this episode
tail spinning
Up next
Yesterday
20VC: Who Wins the Inference Market | Has Open-Source LLM Inference Peaked? | What Happens to the Cost of Compute | The Real Limits of Post-Training and RL with Erik Bernhardsson, Modal CEO
Erik Bernhardsson is the Co-Founder and CEO of Modal, the AI infrastructure platform for training models, running inference and powering AI agents. Modal has raised over $1.2 billion, including a recent $750 million Series D led by Accel at a $15.75BN valuation. The company has s ... Show More
1h 2m
Oct 31
20VC: David Tisch on Why High Ownership and Concentration is BS | Why No Manager Actually Wants to Stay Small | Why Competing with the Mega Platforms is a Losing Game | Why the Lean Startup is a Fake?
David Tisch is the Founder of Box Group, one of the best seed funds of the last decade with early investments in Cursor, Baseten and Clay to name a few. Today the fund invests from two funds, a $275M seed fund and a $275M opportunity fund. AGENDA: 10:40 Why we have less dilution ... Show More
1h 16m
Oct 29
20VC: Anthropic Files S1 Ahead of $2TRN IPO | Instinct's Rumoured $30 Billion Fundraise | Microsoft Laysoff 27,000 While Meta Taps Equity Markets for $95 Billion Capex Spending Spree
AGENDA: 04:00 Anthropic Files S-1 Ahead of $2TRN IPO 14:50 Microsoft Offers Buyouts to 60,000 Employees 20:45 Zuckerberg Taps Equity Markets for $95 Billion AI Spending Spree 23:00 DeepSeek Raises $15 Billion as Chinese AI Faces US Backlash 34:45 OpenAI and Wiz Uncover Decade-Old ... Show More
1 h
Recommended Episodes
Aug 2021
372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe
You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-mad ... Show More
53m 20s
Jun 2025
23andMe's Fatal Flaw | Great Expectorations | 1
When Silicon Valley power-player Anne Wojcicki sees gold in genetics, she forms 23andMe. She wants to bring genetic testing to the masses. But behind the hype and celebrity endorsements, can she build a company that’s selling more than just an expensive novelty product? Be the fi ... Show More
36m 42s
Aug 2024
How 23andMe went from a $6 billion valuation to trading for pennies
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More
54m 45s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s
Dec 2023
Genomes Unlocked: Anne Wojcicki's Vision for 23andMe and the Future of Proactive Healthcare | E1858
This Week in Startups is brought to you by… CLA - Get started with CLA's CPAs, consultants, and wealth advisors now at https://www.claconnect.com/tech House of Macadamias - Get a free month's supply of Macadamia Milk with any order at https://www.houseofmacadamias.com/twist by us ... Show More
1h 16m
Jun 2025
23andMe's Fatal Flaw | Defying Gravity? | 2
Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newe ... Show More
39m 17s
Mar 2021
a16z Bio + Health #7: The Power of Patient Data with Anne Wojcicki
On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala, Jorge Conde, Julie Yoo, and Vijay Pande, along with a16z cofounder Marc Andreessen, talk to guest Anne Wojcicki, CEO of 23andme. The conversation covers the shifting trends and perceptions at ... Show More
37 m
Apr 2024
Extra: Why Is 23andMe Going Under? (Update)
<p>Five years ago, we published an episode about the boom in home DNA testing kits, focusing on the high-flying firm 23andMe and its C.E.O. Anne Wojcicki. Their flight has been extremely bumpy since then. This update includes an additional interview with the <i>Wall Street Journa ... Show More
1h 2m